Although analyses of the impact of cost on treatment preferences is not as robust as the full DCE, there is a clear trend that suggests that cost is important to some patients when evaluating treatment options.
← all excerpts
Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United States.
1
—
—